surmount-osa trial tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized Tirzepatide Eases Obstructive Sleep Apnea
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



























